Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

In this substantial population of patients with RTI, most experienced a rapid improvement of symptoms commonly associated with RTIs after moxifloxacin treatment. Over 89% of patients were judged ...

Treatment of isoniazid- and rifampin-susceptible TB in adults: A 4-month regimen of isoniazid, rifapentine, moxifloxacin, and ...